12
March 2026
Immunotherapy response in pleural mesothelioma modulated by histomolecular features and myeloid composition: From clinical trials to in vitro modeling
Guillaume Tosato (Functional genomics of solid tumors (FunGeST), mesothelioma group, Centre de Recherche des Cordeliers, Paris)
Seminar
Conference room Rosalind Franklin